The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Teriparatide Acetate (hPTH (1-34))
Teriparatide Acetate (hPTH (1-34)) · TERIPARATIDE ACETATE 1 g/g · Powder · Bachem Americas, Inc.
NDC 52416-0126-01 · 1 g in 1 BOTTLE, GLASS · EXPORT ONLY · View full market →
Medicare Part D
This product is labeled for export only and is not sold to US patients, so Medicare does not price it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Teriparatide Acetate (hPTH (1-34)) (Powder)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bachem Americas, Inc. | TERIPARATIDE ACETATE 1 g/g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Teriparatide Acetate (hPTH (1-34)) — NDC 52416-0126-01," retrieved September 3, 2026, https://drugdashboards.com/drug/52416012601.
Free to cite with attribution — see how the data is put together.